(Q70733737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

HLA-DR beta chain residue 86 controls DR alpha beta dimer stability (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

Verreck FA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Termijtelen A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Koning F

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 June 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

1346-1350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

Purification and structural characterisation of human HLA-linked B-cell antigens

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Human B cell alloantigens: separation from other membrane molecules by affinity chromatography

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

A role for peptide in determining MHC class II structure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Irreversible association of peptides with class II MHC molecules in living cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

The implications of subunit interactions for the structure of the T cell receptor-CD3 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

A mouse monoclonal antibody detecting a DR-related MT2-like specificity: Serology and biochemistry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak crossreacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differenti

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Two new HLA DRB1 alleles found in African Americans: implications for balancing selection at positions 57 and 86

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

HLA-DRB1 first domain sequence for a novel DR4 allele designated DRB1*0413

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Further DNA sequence microheterogeneity of the HLA-DR4/Dw13 haplotype group: importance of amino acid position 86 of the DR beta 1 chain for T-cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

DR-restricted T-cell reactivities associated with the Dw19 specificity can be directed against the products of either locus DRB3 (DRw52c) or locus DRB1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

The impact of naturally occurring DR3 microvariants, DRw17 and DRw18, on T-cell allorecognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

HLA class II nucleotide sequences, 1991.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Nomenclature for factors of theHLA system, 1991

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230624

7 January 2021

Identifiers

DOI

10.1002/EJI.1830230624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500529%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference